Precision Medicine Executive, Gulf Coast

Locations: Dallas TX, Houston TX, San Antonio TX, Austin TX

How will your role help us transform hope into reality?

The Precision Medicine Executive (PME), Region will play a meaningful role setting the foundation for commercial success as we deliver through multiple product launches and indication expansions for patients with solid tumors and a rare hematologic disorder. The primary focus will be to improve the diagnosis of systemic mastocytosis to support the commercial success of AYVAKIT. You will be responsible for driving adoption and utilization of quality diagnostic testing in key accounts to identify patients who may be candidates for Blueprint Medicines' portfolio of precision therapies in oncology and rare diseases, with a focus on systemic mastocytosis. You will report to the Director, Precision Medicine Executive Field Leader and be a key member of an efficient, effective, and highly collaborative field team regionally aligned with field sales.

What will you do?

• Cross-functional team responsibilities:
• Be responsible for cultivating stakeholder relationships and developing account-specific plans to facilitate use of high quality, biomarker/genomic testing to ensure optimal diagnosis
• Demonstrate knowledge of, access to, and the ability to build and manage relationships with all key stakeholders in targeted accounts (Pathologist, Executive Leadership, Lab personnel, etc.)
• Apply strong technical acumen to effectively educate on diagnostic testing and disease state to key stakeholders (including broader care team and treating clinicians) and how it fits in the treatment paradigm in SM.
• Deliver educational materials and programs, partnering with marketing, sales, and medical affairs appropriately
• Proactively identify and communicate customer issues, educational opportunities, and market developments with regional partners and broader Precision Medicine team
• Serve as a diagnostics subject matter expert for the region
• Develop business plans for each target account aligned to strategic imperatives
• Represent Blueprint Medicines at congresses and medical meetings, including pathology meetings
• Form relationships with diagnostic laboratories and identify partnership opportunities
• Travel within the US on a regular basis, which may include overnight and weekend travel
• Align with regulatory guidelines, public policies/guidelines, and corporate policies and procedures

What minimum qualifications do we require?

• BA/BS degree OR equivalent work experience required
• 5+ years' experience in biotech, pharma or diagnostic laboratory setting
• Resides within the territory

What additional qualifications will make you a stronger candidate?

• MBA, advanced degree in life sciences, medical or pharmacy degree preferred
• Strong technical background in pathology, molecular biology and/or diagnostics applicable to hematology, oncology or rare diseases
• Demonstrated success across multiple drug launches in applicable specialty markets
• Understanding of diagnostics market considerations including regulatory, reimbursement, and policy, as well as familiarity with patient, provider, and payer perspectives on diagnostic testing
• Strong oral and written communication skills
• Robust analytical and problem-solving skills, ability to identify and action on creative solutions
• Ability to establish credibility, connect the dots and align multiple stakeholders to pioneer the adoption of new products, methods and technologies
• A teammate able to collaborate effectively with a broad range of partners, influence without authority, gain consensus, and act independently in a fast-paced, entrepreneurial environment
• Flexibility and the ability to plan and nimbly adapt to changing conditions
• Motivated by patient focus, urgency and personal dedication to high performance, results and compliance
• Possesses high integrity and exceptional work ethic
• Commitment to our Core Values: Patients First, Thoughtfulness, Urgency, Trust, Optimism

Why Blueprint?

At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success.

This is the place where the extraordinary becomes reality, and you could be part of it.

Patients are waiting. Are you ready to make the leap?

Equity, Diversity, Inclusion and Affirmative Action

At Blueprint Medicines, we foster a culture of equity, diversity and inclusion. A proud Equal Employment Opportunity and Affirmative Action employer, we consider all qualified applicants without regard to race, color, sex, gender identity or expression, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable law. We are also an E-Verify Employer. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out to TotalRewards@blueprintmedicines.com.

For more information, please see our EEO-AA Policy Statement, the EEO Know Your Rights Poster, as well as our Pay Transparency Statement.

Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors.

#LI-Remote